Objectives Perform a systematic literature review (SLR) on risk and prognosis of SARS-CoV-
2 infection and vaccination against SARS-CoV-2 in patients with rheumatic and …

Hyperactivation of immune responses resulting in excessive release of pro-inflammatory
mediators in alveoli/lung structures is the principal pathological feature of coronavirus …

Objectives To estimate absolute and relative risks for all-cause mortality and for severe
COVID-19 in inflammatory joint diseases (IJDs) and with antirheumatic therapies. Methods …

В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2),
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …

The COVID-19 pandemic has resulted in more than 2 million deaths globally. Two
interconnected stages of disease are generally recognised; an initial viral stage and a …

Abstract The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a
betacoronavirus responsible for the COVID-19 pandemic, causing respiratory disorders, and …

Abstract Purpose of Review To review the impact of disease-modifying antirheumatic drugs
(DMARDs) on COVID-19 severity and vaccine immunogenicity and to discuss COVID-19 …

The use of data has been essential throughout the unfolding COVID-19 pandemic. We have
needed it to populate our models, inform our understanding, and shape our responses to the …

Hydroxychloroquine in the prevention of COVID-19 mortality - The Lancet Rheumatology Skip
to Main Content Advertisement The Lancet Rheumatology Home Submit Article Log in Register …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel contagion
that has infected over 113 million people worldwide. It is responsible for the coronavirus …